Treatment sequences for advanced renal cell carcinoma: A health economic assessment

OBJECTIVE: Advanced renal cell carcinoma (RCC) is commonly treated with vascular endothelial growth factor or mammalian target of rapamycin inhibitors. As new therapies emerge, interest grows in gaining a deeper understanding of treatment sequences. Recently, we developed a patient-level, discretely...

Descripción completa

Detalles Bibliográficos
Autores principales: Deniz, Baris, Ambavane, Apoorva, Yang, Shuo, Altincatal, Arman, Doan, Justin, Rao, Sumati, Michaelson, M. Dror
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715231/
https://www.ncbi.nlm.nih.gov/pubmed/31465470
http://dx.doi.org/10.1371/journal.pone.0215761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715231/
https://www.ncbi.nlm.nih.gov/pubmed/31465470
http://dx.doi.org/10.1371/journal.pone.0215761

Ejemplares similares